Morgan Stanley downgraded Clarivate (CLVT) to Underweight from Equal Weight with a price target of $3, down from $5. The firm sees continued share underperformance for Clarivate as its turnaround “continues to struggle.” The company faces tight budgets and competition, and its strategic review will not yield much value, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
- Clarivate launches Cortellis Regulatory Intelligence AI Assistant
- Clarivate’s Mixed Financial Signals Lead to Hold Rating Despite Revenue Beat
- Clarivate files automatic mixed securities shelf
- Clarivate files to sell 245.08M ordinary shares for holders
- Clarivate price target lowered to $4.20 from $4.80 at Goldman Sachs